Highmark, Carnegie Mellon to announce academic partnership
Highmark and Carnegie Mellon University will announce the details of an academic partnership on Monday morning.
Highmark spokesman Aaron Billger declined to comment on the arrangement, described in a one-line news release as designed to “leverage innovation in Allegheny Health Network.”
Highmark CEO Dr. Bill Winkenwerder and CMU officials will make a joint announcement at 10 a.m.
CMU spokesman Ken Walters also declined to elaborate.
Last fall, a CMU publication introducing Dr. Alan Russell as the university's Highmark Distinguished Career Professor said such a partnership would be forthcoming.
“Over the next several months, teams from Carnegie Mellon University, Highmark and clinical partners from the region and beyond will develop strategic science and engineering-driven programs,” it said.
Russell, executive director of the Pittsburgh Tissue Engineering Initiative, was the founding director of the University of Pittsburgh's McGowan Institute for Regenerative Medicine in 2001 and served there until he left Pitt in 2011.
A senior adviser to Highmark, Russell is director of CMU's new Disruptive Health Technology Initiative, a center described as working to improve “affordability, accessibility, quality and simplicity of health care solutions.”
Allegheny Health Network is the hospital system that insurer Highmark is developing with its purchase of West Penn Allegheny Health System.
Debra Erdley is a staff writer for Trib Total Media. She can be reached at 412-320-7996 or email@example.com.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Pirates reassign Liz to make roster room for Morton
- Cops: Man shoots 11-year-old with BB gun; boy is critical
- Police charge Allentown teen for beating, holding ex-girlfriend at gunpoint
- Rossi: After L.A., NFL should tread carefully
- Couple attempts theft at North Huntingdon Wal-Mart
- Posthumous election wins have happened in Western Pa., nation
- Early success in White House race a pleasant surprise for Carson
- Pedestrian injured in accident near busway ramp in Carnegie
- Wrong-way driver causes head-on crash in Center
- Acme man’s ephemeral sculptures appear to defy laws of physics
- Oncologists wary of scaled-back guidelines in cancer screenings